The Latest "Buzz on the Street" Show: Featuring AREV Brands International (CSE: AREV) Report | Financial Buzz

The Latest “Buzz on the Street” Show: Featuring AREV Brands International (CSE: AREV) Report

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “AREV Announces Major Advancement in Extraction Scalability and Throughput.”

AREV Brands International Ltd. (CSE: AREV) is pleased to announce that it has modified its sub critical “FFE” Fast Freeze Extraction systems to be fully scaleable to handle tonnes of biomass on a continuous bases and has developed a patentable method that increases the ability to separate waxes from biomass on the fly.

AREV Brands International Ltd. produces and delivers functional compounds and ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.

Legalization efforts, which are ever present within the cannabis industry, have steadily attracted new consumers each year. In particular, Baby Boomers have seen a large influx of users over recent years; In a survey by MJ Freeway and New Frontier Data, U.S. sales by consumers 55 years or older have increased by 50% since 2015. These consumers alone now account for 29% of medical sales and a quarter of all sales. Currently, the U.S. represents the largest cannabis marketplace, primarily due to states that have already legalized recreational cannabis such as California and Colorado. Since 2015, retail flower prices have fallen significantly as the price per ounce dropped by 25% due to a 40% drop in consumer demand. On the other hand, the concentrate segment is garnering attention as shares of the concentrate market has grown by 138% since 2015, from 16% of all retail sales to 38% in late 2018. Additionally, while 60% of consumers in the survey said they spend less than USD 50 each time they purchase cannabis-based products, many of these consumers purchase more products multiple times within a month, with nearly half of the consumers surveyed stating they spend more than USD 100 per month on cannabis. In combination, all these factors are further propelling the cannabis market. Additionally, the market is also expected to grow pending on international legalization efforts, where most of the countries currently examining the plant are expected to follow a medical legalization path, while also prompting other countries to examine the market. According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016. By 2023, the market is expected to reach USD 65 Billion, growing at a CAGR of 37% during the forecasted period. AREV Brands International Ltd. (CSE: AREV), Aleafia Health Inc. (OTC: ALEAF) (TSX: ALEF), Lifestyle Delivery Systems, Inc. (OTC: LDSYF) (CSE: LDS), InMed Pharmaceuticals, Inc. (OTC: IMLFF) (TSX: IN), MYM Nutraceuticals Inc. (OTC: MYMMF) (CSE: MYM)

The cannabis industry has grown tremendously over the past few years, however, the plant still remains federally enforced in almost every country. So far, cannabis remains strictly regulated due to its marijuana derivative, which grants consumers psychoactive effects stemming from its THC compound. However, Harvard’s Medical School publishing organization has cited various studies which showed that CBD can potentially be an option for treating various medical conditions such as chronic pain, anxiety, inflammation, and notably epilepsy. Strong evidence of effective CBD treatments for childhood epilepsy such as Dravet syndrome and Lennox-Gastaut syndrome have even led the U.S. Food and Drug Administration to legalize Epidiolox, which the first ever cannabis-based drug to be approved by the FDA. However, the FDA has not moved to classify cannabis as a registered medicine for other treatments due to the lack of large-scale clinical trials. However, companies and researchers are keen to keep expanding and improving studies to further add credibility to the CBD compound. “CBD has a number of known properties beneficial to the human condition, and research is just beginning,” Aster Farms President Sam Ludwig told Civilized. “There are two markets for CBD: as a supplement, mild pain reliever and relaxant, and in larger doses, as a truly beneficial remedy for a variety of serious illnesses. There is no doubt it will be dominant supplement for years to come. CBD-heavy flower can be a very effective relaxant for both mind and body. However, people looking for CBD only will find the cleanest and most focused relief in the form of tinctures and capsules. We think the CBD flower market is a trend and will give way to the more concentrated forms. Like an Omega-3 for the body and mind.”

For more information, please visit: AREV Brands International Ltd.

For more corporate news on AREV Brands International Ltd., check out the Buzz on the Street

About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Sponsored Content Release. Click for Full Disclosure

3 Comments
  1. Tony Angelucci 7 months ago
    Reply

    Now if we can get doctor’s to be retrained on the benefits of cannabis and also bring the price down lower than I can get it on the black market we might actually benefit people who need help with a range of illness and pain

  2. Daniel Borough 7 months ago
    Reply

    $AREV is this the start of a bottom reversal?

    • Chris Flanders 7 months ago
      Reply

      Golden crossover complete followed by 3 positive closes
      STO att attention – RSI powering up

Leave a Comment

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For arev brands international ltd. financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.